This data suggests that a combined IHC panel detecting MYBL2, FOXM1, RAD51, CHK1, and XRCC1 could be used to reliably identify MYBL2 High lung adenocarcinomas. This evidence concerns the gene CHEK1 and lung adenocarcinoma.